SAN FRANCISCO, CALIFORNIA--(Marketwired - May 7, 2014) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today announced that it will host an interactive Q&A earnings call at 4 p.m. EST on Wednesday, May 21, 2014, to provide in depth data and analysis about Q2 FY 2014 results. Full results from the quarter will be released after market close Tuesday, May 20th, 2014, and will be available on sedar.com.
Participants for PHM will be Michael Dalsin (Chairman and CEO), Roger Greene, (Executive Director) and Andrew Folmer (President and CFO).
The details of the call are:
Wednesday, May 21st, 2014 at 4pm EST
US & Canada Toll Free - 800-768-2481
Financial professionals are invited to call in and ask questions. To pre-register as a qualified caller, please email firstname.lastname@example.org by 12 p.m. EST Monday, May 19th, 2014.
PHM is an acquisition-oriented, fast-growing and profitable company servicing patients with heart disease and other chronic health conditions. PHM is focused on acquiring companies in a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively identifying and evaluating profitable, annuity-based companies to acquire at favorable prices for their patient databases and technical expertise. PHM's post-acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.